close the form

Spiramycin tablets 1.5M IU for congenital toxoplasmosis (Sanofi, toxoplasmosis, gondii, Rovamycin)

Product Code:
USD 489

What are Spiramycin tablets 1.5MIU for congenital toxoplasmosis (gondii, Rovamycin)?

Spiramycin, classified as a macrolide antibiotic, serves a dual purpose as both an antibiotic and an antiparasitic agent. Functioning by impeding protein synthesis within bacterial and parasite cells, this compound exhibits efficacy against a spectrum of microorganisms, notably encompassing:

Cocci and rods categorized as Gram-positive.

  • Gram-negative cocci.
  • Legionellae bacteria.
  • Mycoplasmas.
  • Chlamydiae pathogens.
  • Specific strains of spirochetes.
  • Cryptosporidium species.
  • Toxoplasma gondii.

Of particular significance is Spiramycin's role in maternal health during pregnancy. The application of Spiramycin tablets is instrumental in mitigating the manifestations of congenital toxoplasmosis, a condition that can affect unborn infants. This medicinal intervention not only combats the presence of Toxoplasma gondii, the causative agent of toxoplasmosis, but also exerts a preventive influence against the transmission of toxoplasmosis across the placenta. By doing so, it substantially diminishes the probability of fetal infection.

Empirical investigations underscore the positive outcomes associated with Spiramycin administration to expectant mothers grappling with acute toxoplasmosis. Notably, a remarkable 94% of pregnant individuals, following Spiramycin treatment, exhibited the absence of amniotic fluid containing toxoplasma, further corroborating the compound's efficacy in curtailing intrauterine transmission.

In summary, Spiramycin's multifaceted antibiotic and antiparasitic properties equip it to counteract a diverse range of microorganisms. In the context of pregnancy, its use holds significant benefits, as it not only targets Toxoplasma gondii but also hampers the transmission of toxoplasmosis to the fetus. This evidence-based approach has shown substantial promise in safeguarding maternal and fetal well-being, fostering a safer gestational environment for both mother and child.

Active principles: spiramycin

Amount: 96 tablets

Maker: Sanofi K. K., Tokyo, Japan

Indications: suppress the symptoms of congenital toxoplasmosis in pregnant women

How to take

Pregnant women should take 2 tablets (3 millions IU of active principle) at a time, 3 times a day.

Contraindications: do not use for breastfeeding women. 

Important information

If an allergic reaction occurs, patient needs to stop using the medicine and consult with their doctor. If patient is taking any other medication or treatment, they should consult with their doctor in advance.

Write a review

Specials of Month

Glanatec ophthalmic solution 0.4% eye drops
Glanatec ophthalmic solution 0.4% eye drops
Kowa Pharmaceuticals
USD 209
News / blog

Scientific Endorsement of Eclar Plaster with Deprodone Propionate for Alleviating Inflammation, Scarring, and Keloids

Is Eclar Plaster with Deprodone Propionate Really Effective? Eclar plaster, enhanced with depro..
100% Money Back Guarantee
100% Money Back Guarantee
Guaranteed 100% refund for lost / heavily damaged insured items, payment system’s full protection and money-back guarantees.
Worldwide Delivery
Worldwide Delivery
Worldwide delivery to almost any country by Japan Post or courier services. Fast and reliable with tracking.
Discrete Stealth shipping provided
Discrete Stealth shipping provided
We state different content and may reduce price upon request. We can also ship from a different name if needed.
Customer Reviews
Customer Reviews
Real tracking numbers’ report for customers published monthly, real useful customer reviews and feedback data updated on constant basis.
Success: You have added
Japan Health Center
Product name